Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Aztreonam plus Clavulanate, Tazobactam, or Avibactam for Treatment of Infections Caused by Metallo-β-Lactamase-Producing Gram-Negative Bacteria.

Emeraud C, Escaut L, Boucly A, Fortineau N, Bonnin RA, Naas T, Dortet L.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e00010-19. doi: 10.1128/AAC.00010-19. Print 2019 May.

PMID:
30858212
2.

Germs of thrones - spontaneous decolonization of Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococci (VRE) in Western Europe: is this myth or reality?

Davido B, Moussiegt A, Dinh A, Bouchand F, Matt M, Senard O, Deconinck L, Espinasse F, Lawrence C, Fortineau N, Saleh-Mghir A, Caballero S, Escaut L, Salomon J.

Antimicrob Resist Infect Control. 2018 Aug 13;7:100. doi: 10.1186/s13756-018-0390-5. eCollection 2018.

3.

Genetic and Biochemical Characterization of OXA-535, a Distantly Related OXA-48-Like β-Lactamase.

Dabos L, Jousset AB, Bonnin RA, Fortineau N, Zavala A, Retailleau P, Iorga BI, Naas T.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e01198-18. doi: 10.1128/AAC.01198-18. Print 2018 Oct.

4.

Evaluation of the CRE and ESBL ELITe MGB® kits for the accurate detection of carbapenemase- or CTX-M-producing bacteria.

Girlich D, Bernabeu S, Fortineau N, Dortet L, Naas T.

Diagn Microbiol Infect Dis. 2018 Sep;92(1):1-7. doi: 10.1016/j.diagmicrobio.2018.02.001. Epub 2018 Feb 9.

PMID:
29983286
5.

Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France.

Dortet L, Glaser P, Kassis-Chikhani N, Girlich D, Ichai P, Boudon M, Samuel D, Creton E, Imanci D, Bonnin R, Fortineau N, Naas T.

J Antimicrob Chemother. 2018 Jan 1;73(1):41-51. doi: 10.1093/jac/dkx370.

6.

OXA-244-Producing Escherichia coli Isolates, a Challenge for Clinical Microbiology Laboratories.

Hoyos-Mallecot Y, Naas T, Bonnin RA, Patino R, Glaser P, Fortineau N, Dortet L.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00818-17. doi: 10.1128/AAC.00818-17. Print 2017 Sep.

7.

Performance of the Xpert® Carba-R v2 in the daily workflow of a hygiene unit in a country with a low prevalence of carbapenemase-producing Enterobacteriaceae.

Hoyos-Mallecot Y, Ouzani S, Dortet L, Fortineau N, Naas T.

Int J Antimicrob Agents. 2017 Jun;49(6):774-777. doi: 10.1016/j.ijantimicag.2017.01.025. Epub 2017 Apr 12.

PMID:
28411078
8.

Inventory of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in France as Assessed by a Multicenter Study.

Robin F, Beyrouthy R, Bonacorsi S, Aissa N, Bret L, Brieu N, Cattoir V, Chapuis A, Chardon H, Degand N, Doucet-Populaire F, Dubois V, Fortineau N, Grillon A, Lanotte P, Leyssene D, Patry I, Podglajen I, Recule C, Ros A, Colomb-Cotinat M, Ponties V, Ploy MC, Bonnet R.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e01911-16. doi: 10.1128/AAC.01911-16. Print 2017 Mar.

9.

First Occurrence of OXA-72-Producing Acinetobacter baumannii in Serbia.

Dortet L, Bonnin RA, Bernabeu S, Escaut L, Vittecoq D, Girlich D, Imanci D, Fortineau N, Naas T.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):5724-30. doi: 10.1128/AAC.01016-16. Print 2016 Oct.

10.

Adenosine deaminase is a useful biomarker to diagnose pleural tuberculosis in low to medium prevalence settings.

Michot JM, Madec Y, Bulifon S, Thorette-Tcherniak C, Fortineau N, Noël N, Lambotte O, El Jahiri Y, Delacour H, Delfraissy JF, Blanc FX.

Diagn Microbiol Infect Dis. 2016 Mar;84(3):215-20. doi: 10.1016/j.diagmicrobio.2015.11.007. Epub 2015 Nov 10.

PMID:
26707067
11.

Whole-Genome Sequence of a European Clone II and OXA-72-Producing Acinetobacter baumannii Strain from Serbia.

Dortet L, Bonnin RA, Girlich D, Imanci D, Bernabeu S, Fortineau N, Naas T.

Genome Announc. 2015 Dec 10;3(6). pii: e01390-15. doi: 10.1128/genomeA.01390-15.

12.

About the usefulness of contact precautions for carriers of extended-spectrum beta-lactamase-producing Escherichia coli.

Zahar JR, Poirel L, Dupont C, Fortineau N, Nassif X, Nordmann P.

BMC Infect Dis. 2015 Nov 12;15:512. doi: 10.1186/s12879-015-1244-x.

13.

Endoscopy-associated transmission of carbapenemase-producing Enterobacteriaceae: return of 5 years' experience.

Dortet L, Naas T, Boytchev I, Fortineau N.

Endoscopy. 2015 Jun;47(6):561. doi: 10.1055/s-0034-1392098. Epub 2015 Jun 1. No abstract available.

PMID:
26030891
14.

[Infective endocarditis caused by Streptococcus sinensis].

Seta V, Teicher E, Fortineau N, Ladouceur M, Lambotte O.

Med Mal Infect. 2015 Jan-Feb;45(1-2):56-7. doi: 10.1016/j.medmal.2014.11.001. Epub 2014 Nov 14. French. No abstract available.

PMID:
25481726
15.

In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis.

Dortet L, Anguel N, Fortineau N, Richard C, Nordmann P.

Int J Infect Dis. 2013 Nov;17(11):e1076-7. doi: 10.1016/j.ijid.2013.02.019. Epub 2013 Apr 9.

16.

Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience.

Fournier S, Brossier F, Fortineau N, Gillaizeau F, Akpabie A, Aubry A, Barbut F, Chedhomme FX, Kassis-Chikhani N, Lucet JC, Robert J, Seytre D, Simon I, Vanjak D, Zahar JR, Brun-Buisson C, Jarlier V.

Euro Surveill. 2012 Jul 26;17(30). pii: 20229.

17.

Proficiency of PCR in hospital settings for nonculture diagnosis of invasive meningococcal infections.

Hong E, Barraud O, Bidet P, Bingen E, Blondiaux N, Bonacorsi S, Burucoa C, Carrer A, Fortineau N, Couetdic G, Courcol R, Garnier F, Hery-Arnaud G, Lanotte P, Le Bars H, Legrand-Quillien MC, Lemée L, Mereghetti L, Millardet C, Minet J, Plouzeau-Jayle C, Pons JL, Schneider J, Taha MK.

Clin Lab. 2012;58(3-4):343-6.

PMID:
22582511
18.

NDM-1-producing Acinetobacter baumannii from Algeria.

Boulanger A, Naas T, Fortineau N, Figueiredo S, Nordmann P.

Antimicrob Agents Chemother. 2012 Apr;56(4):2214-5. doi: 10.1128/AAC.05653-11. Epub 2012 Jan 30. No abstract available.

19.

Emergence of OXA-48-producing Escherichia coli clone ST38 in France.

Poirel L, Bernabeu S, Fortineau N, Podglajen I, Lawrence C, Nordmann P.

Antimicrob Agents Chemother. 2011 Oct;55(10):4937-8. doi: 10.1128/AAC.00413-11. Epub 2011 Jul 18. No abstract available.

20.

Cross-border transmission of OXA-48-producing Enterobacter cloacae from Morocco to France.

Poirel L, Ros A, Carrër A, Fortineau N, Carricajo A, Berthelot P, Nordmann P.

J Antimicrob Chemother. 2011 May;66(5):1181-2. doi: 10.1093/jac/dkr023. Epub 2011 Feb 3. No abstract available.

PMID:
21393189
21.

International transfer of NDM-1-producing Klebsiella pneumoniae from Iraq to France.

Poirel L, Fortineau N, Nordmann P.

Antimicrob Agents Chemother. 2011 Apr;55(4):1821-2. doi: 10.1128/AAC.01761-10. Epub 2011 Jan 18. No abstract available.

22.

Low carriage of vancomycin-resistant enterococci in the digestive tract of French hospitalised patients: a nationwide prospective study in 2006.

Fortineau N, Bourdon N, Leclercq R, Vachée A, Delarbre JM, Maugat S, Robert J; ONERBA.

J Hosp Infect. 2011 Feb;77(2):179-81. doi: 10.1016/j.jhin.2010.10.001. Epub 2011 Jan 7. No abstract available.

PMID:
21216037
23.

Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009.

Carbonne A, Thiolet JM, Fournier S, Fortineau N, Kassis-Chikhani N, Boytchev I, Aggoune M, Seguier JC, Senechal H, Tavolacci MP, Coignard B, Astagneau P, Jarlier V.

Euro Surveill. 2010 Dec 2;15(48). pii: 19734.

24.

Fatal cerebral malaria diagnosed after death in a French patient.

Alunni-Perret V, Vandenbos F, Kechkekian A, Marty P, Legros F, Michiels JF, Cardot-Leccia N, Fortineau N, Durant J, Quatrehomme G.

Am J Forensic Med Pathol. 2010 Sep;31(3):269-72. doi: 10.1097/PAF.0b013e3181e2efe4.

PMID:
20508488
25.

Endoscopy-associated transmission of carbapenem-resistant Klebsiella pneumoniae producing KPC-2 beta-lactamase.

Naas T, Cuzon G, Babics A, Fortineau N, Boytchev I, Gayral F, Nordmann P.

J Antimicrob Chemother. 2010 Jun;65(6):1305-6. doi: 10.1093/jac/dkq117. Epub 2010 Apr 9. No abstract available.

PMID:
20382724
26.

Use of ChromID extended-spectrum beta-lactamase medium for detecting carbapenemase-producing Enterobacteriaceae.

Carrër A, Fortineau N, Nordmann P.

J Clin Microbiol. 2010 May;48(5):1913-4. doi: 10.1128/JCM.02277-09. Epub 2010 Mar 17.

27.

VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae.

Rodriguez-Martinez JM, Nordmann P, Fortineau N, Poirel L.

Antimicrob Agents Chemother. 2010 Jan;54(1):471-6. doi: 10.1128/AAC.00458-09. Epub 2009 Nov 16.

28.

[Cat scratch disease with bone involvement: a case report and literature review].

Roubaud-Baudron C, Fortineau N, Goujard C, Le Bras P, Lambotte O.

Rev Med Interne. 2009 Jul;30(7):602-8. doi: 10.1016/j.revmed.2009.01.015. Epub 2009 Mar 19. Review. French.

PMID:
19303175
29.

Outbreak of CTX-M-15-producing Klebsiella pneumoniae in the intensive care unit of a French hospital.

Carrër A, Lassel L, Fortineau N, Mansouri M, Anguel N, Richard C, Nordmann P.

Microb Drug Resist. 2009 Mar;15(1):47-54. doi: 10.1089/mdr.2009.0868.

PMID:
19231938
30.

[Vancomycin-resistant enterococci: ONERBA networks data and results of the national 2006 survey on digestive carriage].

Fortineau N, Leclercq R, Maugat S, Robert J; Conseil Scientifique de l'ONERBA.

Med Mal Infect. 2008 Jun;38 Suppl 2:S65-7. doi: 10.1016/S0399-077X(08)72995-0. French. No abstract available.

PMID:
18598874
31.

Novel chromogenic medium for detection of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis.

Cuzon G, Naas T, Fortineau N, Nordmann P.

J Clin Microbiol. 2008 Jul;46(7):2442-4. doi: 10.1128/JCM.00492-08. Epub 2008 May 7.

32.

Performance of chromID ESBL, a chromogenic medium for detection of Enterobacteriaceae producing extended-spectrum beta-lactamases.

Réglier-Poupet H, Naas T, Carrer A, Cady A, Adam JM, Fortineau N, Poyart C, Nordmann P.

J Med Microbiol. 2008 Mar;57(Pt 3):310-5. doi: 10.1099/jmm.0.47625-0.

PMID:
18287293
33.

Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.

Nordmann P, Naas T, Fortineau N, Poirel L.

Curr Opin Microbiol. 2007 Oct;10(5):436-40. Epub 2007 Aug 30. Review.

PMID:
17765004
34.

Naturally occurring extended-spectrum cephalosporinases in Escherichia coli.

Mammeri H, Poirel L, Fortineau N, Nordmann P.

Antimicrob Agents Chemother. 2006 Jul;50(7):2573-6.

35.

Nosocomial spread of Pseudomonas aeruginosa isolates expressing the metallo-beta-lactamase VIM-2 in a hematology unit of a French hospital.

Aubron C, Poirel L, Fortineau N, Nicolas P, Collet L, Nordmann P.

Microb Drug Resist. 2005 Fall;11(3):254-9.

PMID:
16201928
36.

First nosocomial outbreak of vancomycin-resistant Enterococcus faecium expressing a VanD-like phenotype associated with a vanA genotype.

Naas T, Fortineau N, Snanoudj R, Spicq C, Durrbach A, Nordmann P.

J Clin Microbiol. 2005 Aug;43(8):3642-9.

37.

Integron-encoded GES-type extended-spectrum beta-lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa.

Poirel L, Brinas L, Fortineau N, Nordmann P.

Antimicrob Agents Chemother. 2005 Aug;49(8):3593-7.

38.

Three-year survey of community-acquired methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a French university hospital.

Naas T, Fortineau N, Spicq C, Robert J, Jarlier V, Nordmann P.

J Hosp Infect. 2005 Dec;61(4):321-9. Epub 2005 Jul 18.

PMID:
16026895
39.

Nosocomial outbreak of staphylococcal scalded skin syndrome in neonates: epidemiological investigation and control.

El Helali N, Carbonne A, Naas T, Kerneis S, Fresco O, Giovangrandi Y, Fortineau N, Nordmann P, Astagneau P.

J Hosp Infect. 2005 Oct;61(2):130-8.

PMID:
16009455
40.
41.

Chromosome-borne class A BOR-1 beta-Lactamase of Bordetella bronchiseptica and Bordetella parapertussis.

Lartigue MF, Poirel L, Fortineau N, Nordmann P.

Antimicrob Agents Chemother. 2005 Jun;49(6):2565-7.

43.

First outbreak of vancomycin-resistant enterococci in a tertiary hospital in Turkey.

Colak D, Naas T, Gunseren F, Fortineau N, Ogunc D, Gultekin M, Nordmann P.

J Antimicrob Chemother. 2002 Sep;50(3):397-401.

PMID:
12205065
44.

Biochemical-genetic characterization of the chromosomally encoded extended-spectrum class A beta-lactamase from Rahnella aquatilis.

Bellais S, Poirel L, Fortineau N, Decousser JW, Nordmann P.

Antimicrob Agents Chemother. 2001 Oct;45(10):2965-8.

45.

SHV-type extended-spectrum beta-lactamase in a Shigella flexneri clinical isolate.

Fortineau N, Naas T, Gaillot O, Nordmann P.

J Antimicrob Chemother. 2001 May;47(5):685-8.

PMID:
11328785
46.

Plasmid-mediated and inducible cephalosporinase DHA-2 from Klebsiella pneumoniae.

Fortineau N, Poirel L, Nordmann P.

J Antimicrob Chemother. 2001 Feb;47(2):207-10.

PMID:
11157909
48.
49.

Fulminant cryptococcal infections in HIV-infected patients on oral fluconazole.

Viard JP, Hennequin C, Fortineau N, Pertuiset N, Rothschild C, Zylberberg H.

Lancet. 1995 Jul 8;346(8967):118. No abstract available.

PMID:
7603189

Supplemental Content

Loading ...
Support Center